Chris joined GTCR in 2013. Prior to joining GTCR, he worked as an Investment Banking Analyst in the Mergers & Acquisitions / Corporate Finance group of Morgan Stanley. Chris graduated cum laude from the University of Notre Dame with a BBA in finance.
Chris works closely with Antylia Scientific, TerSera Therapeutics, Cedar Gate Technologies and Ceba-Tech. He was previously a Director of Riverchase Dermatology and played an instrumental role in GTCR’s investments in Crealta Pharmaceuticals, Curo and Maravai Life Sciences.
This person is not in the org chart
This person is not in any teams